{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T14:34:26Z","timestamp":1771684466680,"version":"3.50.1"},"reference-count":35,"publisher":"Japanese Society of Internal Medicine","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2023,2,15]]},"DOI":"10.2169\/internalmedicine.9815-22","type":"journal-article","created":{"date-parts":[[2022,7,21]],"date-time":"2022-07-21T22:13:21Z","timestamp":1658441601000},"page":"605-611","source":"Crossref","is-referenced-by-count":8,"title":["Acquired von Willebrand Syndrome in a Patient with Multiple Comorbidities, Including MALT Lymphoma with IgA Monoclonal Gammopathy and Hyperviscosity Syndrome"],"prefix":"10.2169","volume":"62","author":[{"given":"Mai","family":"Owari","sequence":"first","affiliation":[{"name":"Department of Hematology, Fukushima Medical University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kayo","family":"Harada-Shirado","sequence":"additional","affiliation":[{"name":"Department of Hematology, Fukushima Medical University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryuichi","family":"Togawa","sequence":"additional","affiliation":[{"name":"Department of Pulmonary Medicine, Fukushima Medical University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahiko","family":"Fukatsu","sequence":"additional","affiliation":[{"name":"Department of Hematology, Fukushima Medical University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuki","family":"Sato","sequence":"additional","affiliation":[{"name":"Department of Hematology, Fukushima Medical University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koichiro","family":"Fukuchi","sequence":"additional","affiliation":[{"name":"Department of Hematology, Fukushima Medical University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mamiko","family":"Endo","sequence":"additional","affiliation":[{"name":"Department of Hematology, Fukushima Medical University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Takahashi","sequence":"additional","affiliation":[{"name":"Department of Hematology, Fukushima Medical University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoshi","family":"Kimura","sequence":"additional","affiliation":[{"name":"Department of Hematology, Fukushima Medical University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tsukasa","family":"Osaki","sequence":"additional","affiliation":[{"name":"Department of Molecular Patho-Biochemistry and Patho-Biology, Yamagata University School of Medicine, Japan"},{"name":"The Japanese Collaborative Research Group (JCRG) on Acquired Coagulopathies supported by the Japanese Ministry of Health, Labor, and Welfare, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masayoshi","family":"Souri","sequence":"additional","affiliation":[{"name":"Department of Molecular Patho-Biochemistry and Patho-Biology, Yamagata University School of Medicine, Japan"},{"name":"The Japanese Collaborative Research Group (JCRG) on Acquired Coagulopathies supported by the Japanese Ministry of Health, Labor, and Welfare, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akitada","family":"Ichinose","sequence":"additional","affiliation":[{"name":"Department of Molecular Patho-Biochemistry and Patho-Biology, Yamagata University School of Medicine, Japan"},{"name":"The Japanese Collaborative Research Group (JCRG) on Acquired Coagulopathies supported by the Japanese Ministry of Health, Labor, and Welfare, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoko","family":"Shibata","sequence":"additional","affiliation":[{"name":"Department of Pulmonary Medicine, Fukushima Medical University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuko","family":"Hashimoto","sequence":"additional","affiliation":[{"name":"Department of Diagnostic Pathology, Fukushima Medical University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takayuki","family":"Ikezoe","sequence":"additional","affiliation":[{"name":"Department of Hematology, Fukushima Medical University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Mital A. Acquired von Willebrand syndrome. Adv Clin Med 25: 1337-1344, 2016.","DOI":"10.17219\/acem\/64942"},{"key":"2","doi-asserted-by":"publisher","unstructured":"2. Ng C, Motto DG, Di Paola J. Diagnostic approach to von Willebrand disease. Blood 125: 2029-2037, 2015.","DOI":"10.1182\/blood-2014-08-528398"},{"key":"3","doi-asserted-by":"crossref","first-page":"319","DOI":"10.3233\/BIR-15061","volume":"52","author":"S Gogia","year":"2015","unstructured":"3. Gogia S, Neelamegham S. Role of fluid shear stress in regulating VWF structure, function and related blood disorders. Biorheology 52: 319-335, 2015.","journal-title":"Biorheology","ISSN":"https:\/\/id.crossref.org\/issn\/0006-355X","issn-type":"print"},{"key":"4","doi-asserted-by":"publisher","unstructured":"4. Fujikawa K, Suzuki H, McMullen B, Chung D. Purification of human von Willebrand factor cleaving protease and its identification as a new member of the metalloprotease family. Blood 98: 1662-1666, 2001.","DOI":"10.1182\/blood.V98.6.1662"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Nichols WL, Hultin MB, James AH, et al. von Willebrand disease (VWD): evidence-based diagnosis and management guidelines, the National Heart, Lung, and Blood Institute (NHLBI) Expert Panel report (USA). Haemophilia 14: 171-232, 2008.","DOI":"10.1111\/j.1365-2516.2007.01643.x"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. James PD, Connell NT, Ameer B, et al. ASH ISTH NHF WFH 2021 guidelines on the diagnosis of von Willebrand disease. Blood Adv 5: 280-300, 2021.","DOI":"10.1182\/bloodadvances.2020003265"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Federici AB, Rand JH, Bucciarelli P, et al; Subcommittee on von Willebrand Factor. Acquired von Willebrand syndrome: data from an international registry. Thromb Haemost 84: 345-349, 2000.","DOI":"10.1055\/s-0037-1614018"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Shetty S, Kasatkar P, Ghosh K. Pathophysiology of acquired von Willebrand disease: a concise review. Eur J Haematol 87: 99-106, 2011.","DOI":"10.1111\/j.1600-0609.2011.01636.x"},{"key":"9","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/S0140-6736(87)92272-0","volume":"1","author":"RG Dalton","year":"1987","unstructured":"9. Dalton RG, Dewar MS, Savidge GF, et al. Hypothyroidism as a cause of acquired von Willebrand&apos;s disease. Lancet 1: 1007-1009, 1987.","journal-title":"The Lancet","ISSN":"https:\/\/id.crossref.org\/issn\/0140-6736","issn-type":"print"},{"key":"10","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1182\/blood.V64.3.614.614","volume":"64","author":"PM Mannucci","year":"1984","unstructured":"10. Mannucci PM, Lombardi R, Bader R, et al. Studies of the pathophysiology of acquired von Willebrand&apos;s disease in seven patients with lymphoproliferative disorders or benign monoclonal gammopathies. Blood 64: 614-621, 1984.","journal-title":"Blood","ISSN":"https:\/\/id.crossref.org\/issn\/0006-4971","issn-type":"print"},{"key":"11","unstructured":"11. Ihara A, Suzuki N, Matsushita T, Ichinose A. Acquired von Willebrand syndrome in a patient with immune thrombocytopenic purpura. Rinsho Ketsueki (Jpn J Clin Hematol) 56: 901-904, 2015."},{"key":"12","unstructured":"12. Kobayashi N, Ogawa Y, Yanagisawa K, et al. Acquired immune-mediated von Willebrand syndrome accompanied by antiphospholipid syndrome. Rinsho Ketsueki (Jpn J Clin Hematol) 58: 613-618, 2017."},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Richard C, Cuadrado MA, Prieto M, et al. Acquired von Willebrand disease in multiple myeloma secondary to absorption of von Willebrand factor by plasma cells. Am J Hematol 35: 114-117, 1990.","DOI":"10.1002\/ajh.2830350210"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Tamura T, Horiuchi H, Imai M, et al. Unexpectedly high prevalence of acquired von Willebrand syndrome in patients with severe aortic stenosis as evaluated with a novel large multimer index. J Atherosclero Thromb 22: 1115-1123, 2015.","DOI":"10.5551\/jat.30809"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Tiede A, Priesack J, Werwitzke S, et al. Diagnostic workup of patients with acquired von Willebrand syndrome: a retrospective single-centre cohort study. J Thromb Haemost 6: 569-576, 2008.","DOI":"10.1111\/j.1538-7836.2008.02909.x"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Leebeek FW, Eikenboom JC. Von Willebrand&apos;s disease. N Engl J Med 373: 2067-2080, 2016.","DOI":"10.1056\/NEJMra1601561"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Laffan MA, Lester W, O&apos;Donnel JS, et al. The diagnosis and management of von Willebrand disease: a United Kingdom Haemophlia Center Doctors Organization guideline approved by the British Committee for Standards in Haematology. Br J Haematol 167: 453-465, 2014.","DOI":"10.1111\/bjh.13064"},{"key":"18","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1182\/blood.V69.6.1691.1691","volume":"69","author":"JC Gill","year":"1987","unstructured":"18. Gill JC, Endes-Brooks J, Bauer PJ, Marks Jr WJ, Montgomery RR. The effect of ABO blood group on the diagnosis of von Willebrand disease. Blood 69: 1691-1695, 1987.","journal-title":"Blood","ISSN":"https:\/\/id.crossref.org\/issn\/0006-4971","issn-type":"print"},{"key":"19","doi-asserted-by":"crossref","first-page":"3623","DOI":"10.1182\/blood.V91.10.3623","volume":"91","author":"H Mohri","year":"1998","unstructured":"19. Mohri H, Motomura S, Kanamori H, et al. Clinical significance of inhibitors in acquired von Willebrand syndrome. Blood 91: 3623-3629, 1998.","journal-title":"Blood","ISSN":"https:\/\/id.crossref.org\/issn\/0006-4971","issn-type":"print"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Kumar S, Pruthi RK, Nichols WL. Acquired von Willebrand disease. Mayo Clin Proc 77: 181-187, 2002.","DOI":"10.4065\/77.2.181"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Federici AB, Budde U, Castaman G, Rand JH, Tiede A. Current diagnostic and therapeutic approaches to patients with acquired von Willebrand syndrome: a 2013 update. Semin Tromb Hemost 39: 191-201, 2013.","DOI":"10.1055\/s-0033-1334867"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Metha J, Singhal S. Hyperviscosity syndrome in plasma cell dyscrasias. Semin Thromb Hemost 29: 467-471, 2003.","DOI":"10.1055\/s-2003-44554"},{"key":"23","doi-asserted-by":"crossref","first-page":"2707","DOI":"10.1182\/blood.V92.8.2707","volume":"92","author":"AB Federici","year":"1998","unstructured":"23. Federici AB, Stabile F, Castaman G, Canciani MT, Mannucci PM. Treatment of acquired von Willebrand syndrome in patients with monoclonal gammopathy of uncertain significance: comparison of three different therapeutic approaches. Blood 92: 2707-2711, 1998.","journal-title":"Blood","ISSN":"https:\/\/id.crossref.org\/issn\/0006-4971","issn-type":"print"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Kwaan HC. Hyperviscosity in plasma cell dyscrasias. Clin Hemorheol Microcirc 55: 75-83, 2013.","DOI":"10.3233\/CH-131691"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Abou-Ismail MY, Rodgers GM, Bray PF, Lim MY. Acquired von Willebrand syndrome in monoclonal gammopathy - a scoping review on hemostatic management. Res Pract Thromb Haemost 5: 356-365, 2021.","DOI":"10.1002\/rth2.12481"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Heyde EC. Gastrointestinal bleeding in aortic stenosis. N Engl J Med 259: 196, 1958.","DOI":"10.1056\/NEJM195807242590416"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Loscalzo J. From clinical observation to mechanism - Heyde&apos;s syndrome. N Engl J Med 367: 1954-1956, 2012.","DOI":"10.1056\/NEJMcibr1205363"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Horiuchi H, Doman T, kokame K, Saiki Y, Matsumoto M. Acquired von Willebrand syndrome associated with cardiovascular diseases. J Atherosclero Thromb 26: 303-314, 2019.","DOI":"10.5551\/jat.RV17031"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Tefferi A, Hanson CA, Kurtin PJ, Katzmann JA, Dalton RJ, William LN. Acquired von Willebrand&apos;s disease due to aberrant expression of platelet glycoprotein Ib by marginal zone lymphoma cell. Br J Haematol 96: 850-853, 1997.","DOI":"10.1046\/j.1365-2141.1997.d01-2088.x"},{"key":"30","unstructured":"30. Iwabuchi T, Kimura Y, Suzuki T, et al. Successful treatment with rituximab in a patient with primary thymic MALT lymphoma complicated with acquired von Willebrand syndrome and Sj\u00f6gren syndrome. Rinsho Ketsueki (Jpn J Clin Hematol) 52: 210-215, 2011."},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Koyama T, Fujimoto K, Shima M. Acquired von Willebrand syndrome associated with Hashimoto&apos;s thyroiditis and subcutaneous mucosa-associated lymphoid tissue lymphoma. Intern Med 52: 2661-2663, 2013.","DOI":"10.2169\/internalmedicine.52.0825"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. Komeno Y, Shibuya N, Uryu H, et al. Splenic marginal zone lymphoma with acquired von Willebrand syndrome diagnosed via splenic bleeding. Intern Med 56: 557-562, 2017.","DOI":"10.2169\/internalmedicine.56.7258"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33. Fukatsu M, Ohkawara H, Takahashi H, et al. A case of acquired von Willebrand syndrome complicated by acute myelomonocytic leukemia. Case Rep Oncol 14: 1152-1158, 2021.","DOI":"10.1159\/000517439"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34. Boender J, Atiq F, Cnossen MH, et al. Von Willebrand factor multimer densitometric analysis: validation of the clinical accuracy and clinical implications in von Willebrand disease. Hemasphere 17:5: e542, 2021.","DOI":"10.1097\/HS9.0000000000000542"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35. Pikta M, Banys V, Szanto T, et al. Von Willebrand factor multimeric assay in acquired von Willebrand disease diagnosis: a report of experience from North Estonia Medical Center. J Lab Physicians 13: 195-201, 2021.","DOI":"10.1055\/s-0041-1730818"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/62\/4\/62_9815-22\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,10]],"date-time":"2024-05-10T04:31:32Z","timestamp":1715315492000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/62\/4\/62_9815-22\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,15]]},"references-count":35,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.9815-22","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,15]]},"article-number":"9815-22"}}